Integrated Biopharma, Inc.
INBP
$0.32
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 169.10% | -129.13% | 426.72% | -55.21% | -3.36% |
| Total Depreciation and Amortization | 0.00% | 7.57% | -4.40% | -0.63% | 0.95% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -85.95% | 231.01% | 106.40% | -50.59% | 82.01% |
| Change in Net Operating Assets | 277.43% | 26.03% | -55.59% | -104.57% | 80.77% |
| Cash from Operations | 120.14% | -4.06% | 206.47% | -69.41% | 453.23% |
| Capital Expenditure | -1,830.00% | 108.62% | -300.00% | 48.21% | 61.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4,225.00% | 96.55% | -300.00% | 48.21% | 61.64% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1,000.00% | -- | -- | 100.00% | 36.36% |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -116.42% | -- | -100.00% | 357.14% | 36.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 70.80% | 30.80% | 163.16% | -68.01% | 273.18% |